These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1146352)

  • 41. Seminars on diabetes. II. Principles of management.
    Can Med Assoc J; 1971 Nov; 105(9):972-3 passim. PubMed ID: 5150198
    [No Abstract]   [Full Text] [Related]  

  • 42. [Long term effect of tolbutamide on glucose tolerance of asymptomatic and latent diabetics: value of early treatment of diabetes].
    Journ Annu Diabetol Hotel Dieu; 1969; 10():401-5. PubMed ID: 5376997
    [No Abstract]   [Full Text] [Related]  

  • 43. [Influencing the effect of Dirastan (tolbutamide) simultaneous administration of chloramphenicol in patients with diabetes and bacterial urinary tract inflammation (author's transl)].
    Brunová E; Slabochová Z; Platilová H
    Cas Lek Cesk; 1974 Jan; 113(3):72-5. PubMed ID: 4434411
    [No Abstract]   [Full Text] [Related]  

  • 44. [Preliminary results with a new oral antidiabetic drug of the sulfanylurea series: glibenclamide or HB 419].
    Marocco F; Patrito G
    Minerva Med; 1970 Dec; 61(97):5525-42. PubMed ID: 5494124
    [No Abstract]   [Full Text] [Related]  

  • 45. [Glybenclamide and its place among sulfanylureas in the treatment of diabetes mellitus].
    Cabezas Cerrato J; Fernández-Cruz A; Fernández-Cruz A
    Rev Clin Esp; 1970 May; 117(4):375-86. PubMed ID: 5471527
    [No Abstract]   [Full Text] [Related]  

  • 46. [Immediate effect of short-lasting insulin administration on the action of tolbutamide in diabetic patients].
    Grabowska MJ
    Pol Tyg Lek; 1967 Jul; 22(28):1064-6. PubMed ID: 6061141
    [No Abstract]   [Full Text] [Related]  

  • 47. [Functions of the stomach and duodenum in patients with diabetes mellitus].
    Makos' RP; Shavlak VV
    Vrach Delo; 1969 Jun; 6():42-5. PubMed ID: 5821660
    [No Abstract]   [Full Text] [Related]  

  • 48. [Occult forms of diabetes mellitus in atherosclerosis].
    Khaletskiĭ ME
    Vrach Delo; 1972 Jul; 7():30-2. PubMed ID: 5083752
    [No Abstract]   [Full Text] [Related]  

  • 49. A clinical evaluation of glibenclamide (HB 419, "Daonil") a new antidiabetic sulphonylurea.
    Cheah JS
    Singapore Med J; 1972 Apr; 13(2):87-90. PubMed ID: 4625992
    [No Abstract]   [Full Text] [Related]  

  • 50. Oral management of uncomplicated maturity onset diabetes.
    Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT
    J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809
    [No Abstract]   [Full Text] [Related]  

  • 51. [Studies on the course of mass screening in discovered diabetic patients].
    Leupold H
    Z Gesamte Inn Med; 1974 Jul; 29(13):532-6. PubMed ID: 4218418
    [No Abstract]   [Full Text] [Related]  

  • 52. The UGDP--tolbutamide and mortality.
    Knowles HC
    Horm Metab Res; 1974; Suppl 4():186-8. PubMed ID: 4609432
    [No Abstract]   [Full Text] [Related]  

  • 53. Letter: The UGDP scandal and cover-up.
    Moss JM
    JAMA; 1975 May; 232(8):806-8. PubMed ID: 1173182
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical action of a therapeutic combination of a hypoglycemia-inducing sulfonamide and a biguanide in diabetes].
    Linquette M; Fossati P; Fourlinnie JC
    Sem Ther; 1967 Oct; 43(8):450-4. PubMed ID: 5623993
    [No Abstract]   [Full Text] [Related]  

  • 55. Tolbutamide: more questions than answers.
    Barclay WR
    JAMA; 1971 Jan; 215(1):108-9. PubMed ID: 5107341
    [No Abstract]   [Full Text] [Related]  

  • 56. Metformin compared with tolbutamide in the treatment of maturity-onset diabetes mellitus.
    Lim P; Khoo OT
    Med J Aust; 1970 Feb; 1(6):271-3. PubMed ID: 5440868
    [No Abstract]   [Full Text] [Related]  

  • 57. Potentiation of the tolbutamide effect by dicoumarol.
    Kristensen M; Hansen JM
    Diabetes; 1967 Apr; 16(4):211-4. PubMed ID: 4164590
    [No Abstract]   [Full Text] [Related]  

  • 58. Nine years' experience with tolbutamide in the treatment of diabetes.
    Balodimos MC; Camerini-Dávalos RA; Marble A
    Metabolism; 1966 Nov; 15(11):957-70. PubMed ID: 5950894
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug substitution.
    Beers KL
    JAMA; 1979 Sep; 242(10):1031-2. PubMed ID: 470042
    [No Abstract]   [Full Text] [Related]  

  • 60. Avoiding the pitfalls of long-term therapeutic trials: lessons learned from the UGDP study.
    Seltzer HS
    J Clin Pharmacol New Drugs; 1972 Oct; 12(10):393-8. PubMed ID: 4627326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.